BSPM Biostar Pharmaceutic
- 1.05 P/E
- 0.2 P/S
- 0.13 P/B
- -2.223 EPS
- 11.18% Cash ROIC
- 2.55 Cash Ratio
- 0 / 0% Dividend
- 21,739.00 Avg. Vol.
- 11.65M Shares
- 9.2M Market Cap.
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products, and health supplement products for various diseases and conditions in the People's Republic of China. Its primary product includes the Xin Ao Xing Oleanolic Acid Capsule, an OTC medicine for the treatment of chronic hepatitis B. The company's products also include Ganw...
Wall Street Journal (press release) - May 16, 2013
PR Newswire (press release) - May 14, 2013
Yahoo! New Zealand News - May 20, 2013
NASDAQ - May 16, 2013
Business Wire (press release) - 4 hours ago
MarketWatch (press release) - Apr 29, 2013
HealthpointCapital - May 17, 2013
Private Equity Hub (press release) - May 2, 2013
MiBiz - Apr 29, 2013
Reuters Key Development - Dec 21, 2012